Tokyo: Japan's Nikkei stock average fell for a second straight day on Thursday, hurt by the Yen's persistent strength and fears the US might be heading for another recession, with many investors on the sidelines ahead of US economic data. Chip-related shares underperformed after Dell's disappointing sales outlook fanned worries that weaker economic growth will hurt earnings in the third quarter and sent US tech shares tumbling. "The biggest problem...
08:44 AM, Aug 18, 2011
Indian pharma giant has customers in 125 countries and alliances in 49 countries. ...06:08 PM, May 24, 2009
Ranbaxy-Daiichi Sankyo is still good despite the co's trouble with US laws. ...03:47 AM, Sep 18, 2008
The Indian drug giant, Ranbaxy is a major maker of an AIDS generic drug. ...01:45 AM, Sep 17, 2008
Daiichi Sankyo to pump in Rs 10,000 crores to acquire stake in Ranbaxy. ...05:49 PM, Aug 05, 2008
Ranbaxy strongly denied allegations and will file a response later on Monday. ...09:10 PM, Jul 14, 2008
Existing management to continue under CEO and MD, Malvinder Singh. ...02:43 PM, Jun 11, 2008
displayed with permission. Use of the CNN name and/or logo on or as part of CNN-IBN does not derogate from the intellectual property rights of Cable News Network in respect of them.
Disclaimer: Network18 Media & Investments Limited is proposing, subject to market conditions and other considerations, an offer of its equity shares on rights basis and has filed a Draft Letter of Offer with the Securities and Exchange Board of India. The Draft Letter of Offer is available on the website of SEBI at www.sebi.gov.in and the websites of the Lead Managers at www.icicisecurities.com and www.rbs.in Investors should note that investment in equity shares involves a high degree of risk and are requested to refer to "Risk Factors" in the Draft Letter of Offer. The Equity Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act"), or any state securities laws in the United States and may not be offered or sold in the United States or to, or for the account or benefit of, "U.S. persons" (as defined in Regulation S under the US Securities Act) except in a transaction exempt from the registration requirements of the US Securities Act and in accordance with any applicable U.S. state securities laws.
Disclaimer: TV18 Broadcast Limited is proposing, subject to market conditions and other considerations, an offer of its equity shares on rights basis and has filed a Draft Letter of Offer with the Securities and Exchange Board of India. The Draft Letter of Offer is available on the website of SEBI at www.sebi.gov.in and the websites of the Lead Managers at www.icicisecurities.com and www.rbs.in Investors should note that investment in equity shares involves a high degree of risk and are requested to refer to "Risk Factors" in the Draft Letter of Offer. The Equity Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act"), or any state securities laws in the United States and may not be offered or sold in the United States or to, or for the account or benefit of, "U.S. persons" (as defined in Regulation S under the US Securities Act) except in a transaction exempt from the registration requirements of the US Securities Act and in accordance with any applicable U.S. state securities laws.
